Order Article Reprints

López Moreno SF, Lenz SA, Casso-Chapa B, Paniagua-Bojorges A, Kim JH, Palaskas NL, Nead KT, Samanthapudi VSK, Mejia G, Hoang O, et al. SHP2: A Redox-Sensitive Regulator Linking Immune Checkpoint Inhibitor Therapy to Cancer Treatment and Vascular Risk. Antioxidants. 2025; 14(12):1388. https://doi.org/10.3390/antiox14121388

López Moreno, Silvia Fernanda, Stefania Assunto Lenz, Bernardo Casso-Chapa, Angelica Paniagua-Bojorges, Jung Hyun Kim, Nicolas L. Palaskas, Kevin T. Nead, Venkata S. K. Samanthapudi, Gilbert Mejia, Oanh Hoang, and et al. 2025. "SHP2: A Redox-Sensitive Regulator Linking Immune Checkpoint Inhibitor Therapy to Cancer Treatment and Vascular Risk" Antioxidants 14, no. 12: 1388. https://doi.org/10.3390/antiox14121388

López Moreno, S. F., Lenz, S. A., Casso-Chapa, B., Paniagua-Bojorges, A., Kim, J. H., Palaskas, N. L., Nead, K. T., Samanthapudi, V. S. K., Mejia, G., Hoang, O., Lee, J., Lin, S. H., Herrmann, J., Wang, G., Yusuf, S. W., Iliescu, C. A., Beinart, N. I., Manisty, C., Ushio-Fukai, M., ... Abe, J.-i. (2025). SHP2: A Redox-Sensitive Regulator Linking Immune Checkpoint Inhibitor Therapy to Cancer Treatment and Vascular Risk. Antioxidants, 14(12), 1388. https://doi.org/10.3390/antiox14121388